DR. SCOTT A. SHAPIRO, M.D.

Plain English
This study looked at how different amounts of platelets in platelet-rich plasma (PRP) injections affect pain and function in patients with knee osteoarthritis, comparing PRP injections to hyaluronic acid or saline injections. Researchers found that all PRP groups showed better results than hyaluronic acid, with the moderate platelet count group (between 5-10 billion platelets) providing the best improvement in both pain relief and physical function. Specifically, this group had a large impact on patient-reported outcomes, significantly reducing pain and improving function compared to patients receiving saline. Who this helps: This helps patients suffering from knee osteoarthritis looking for effective treatment options.

Plain English
This paper introduces a new guideline to help manage hepatitis B and C infections in people with bleeding disorders, emphasizing the need for careful monitoring, even for those who have cleared the virus in the past. The guideline, based on European recommendations, gives specific advice on assessing liver health and knowing when to refer patients to liver specialists. This matters because it aims to improve the health management of these patients and ensure they receive appropriate care. Who this helps: This benefits patients with bleeding disorders and their healthcare providers.

Plain English
This study looked at the rates of women having to return to the hospital after childbirth and identified which groups were at higher risk for readmission. Out of nearly 300,000 deliveries, the overall readmission rate was 0.5%, but certain groups faced much higher rates, like those with transverse lies or multiple pregnancies, reaching up to 3%. Understanding these risks is crucial because it can lead to targeted interventions to improve care and reduce hospital visits after delivery. Who this helps: This helps new mothers and healthcare providers by improving postpartum care and decreasing hospital readmissions.

Plain English
This study compared two surgical treatments for fractures around knee implants: open reduction and internal fixation (ORIF) and distal femoral replacement (DFR). It found that while patients who had ORIF reported better functional results, such as higher Knee Society Functional Scores (average scores of 53 vs. 39), DFR allowed for quicker weight bearing (2 days vs. 78 days), but did not show a clear advantage in overall mobility after surgery. Additionally, the chance of needing another surgery was higher for those who had ORIF (12% compared to 7% for DFR). Who this helps: This information helps doctors choose the best treatment option for patients with specific types of knee fractures related to implants.

Plain English
This paper discusses the latest advancements in orthobiologics and cellular therapies, which are innovative treatments for muscle and bone issues. The authors emphasize the need for medical professionals to understand these treatments and the regulations surrounding them to ensure that patients receive care based on solid scientific evidence, not just hype. They aim to clarify the terminology and processes involved in these therapies to reduce confusion and support safe, ethical medical practices. Who this helps: This information benefits doctors, patients seeking these treatments, and anyone involved in musculoskeletal care.

Plain English
This research focused on creating guidelines for implementing gene therapy for adults with severe haemophilia A and B in the UK. The study found that recent approvals for gene therapy are a major step forward, and to make these treatments effective, a new plan was needed to outline how they should be delivered. These guidelines will improve the care process by ensuring that healthcare providers work together and use a uniform approach to treatment, benefiting both patients and healthcare teams. Who this helps: Patients with severe haemophilia A and B and their healthcare providers.

Plain English
This study examined how patients with pulmonary arterial hypertension (PAH) who also have heart-related issues respond to treatments with either inhaled or oral treprostinil. Researchers found that patients taking inhaled treprostinil showed improvements in their ability to walk, with those having zero, one, or two cardiovascular comorbidities walking 26 meters, 22 meters, and 21.6 meters farther, respectively, after 12 weeks. Additionally, those on oral treprostinil experienced a reduced risk of their condition worsening by 36% to 45%, depending on the number of comorbidities they had. Who this helps: This research benefits patients with PAH and cardiovascular issues, as well as their doctors by providing effective treatment options.

Plain English
This study looked at patients who received same-day emergency care (SDEC) to see how many developed venous thromboembolism (VTE), a serious condition involving blood clots, within 90 days. Out of over 40,000 visits, only 0.9% of patients (349 individuals) experienced VTE, with older age, a history of cancer, and prior hospital visits raising the risk. This is important because it helps healthcare providers understand if VTE prevention should be applied to SDEC patients, as the risk appears similar to that of traditional inpatient care. Who this helps: This benefits patients receiving same-day emergency care and their doctors in assessing the need for preventative measures.

Plain English
This research focused on improving clinical trials for osteoarthritis (OA) to make them more effective in preventing and treating the disease. The authors found that current trial methods are too focused on advanced OA symptoms and do not account for earlier stages, like pre-osteoarthritis, which can lead to more effective treatments if addressed sooner. By suggesting new ways to design trials that target these early stages and their unique challenges, this research aims to better manage OA and improve patients' quality of life. Who this helps: This benefits patients with osteoarthritis, especially those in the early stages of the disease.

Plain English
This research focused on a genetic variant that affects how specific sugars are added to proteins in patients with IgA nephropathy, a kidney disease. The study revealed that a mutation in the GALNT14 gene leads to changes in how immune cells called B cells behave, causing them to gather in the bloodstream instead of moving to the mucosal areas where they are usually needed. This matters because it helps explain how immune system defects contribute to kidney damage in this condition, highlighting potential new avenues for treatment. Who this helps: Patients with IgA nephropathy.

Plain English
This study looked at how well medical schools in the U.S. prepare future pediatricians to prevent and respond to opioid overdoses in teenagers. Out of 189 schools surveyed, only about 64% included any training on this topic, and none covered all the important areas needed. Most schools did not teach essential topics like naloxone use or fentanyl test kits, which shows a clear need for better training on opioid overdose prevention. Who this helps: This helps patients, especially adolescents at risk for opioid overdose, and the pediatricians who care for them.

Plain English
This study looked at calls to poison control centers in California regarding glucagon-like peptide-1 receptor agonists (GLP-1 RAs), especially after the approval of Wegovy for weight management in 2021. They found that calls about GLP-1 RA exposure increased by about 1.16 cases each month, with 21% of those needing emergency treatment. It’s important because while many cases were managed at home, there were still significant risks, including some cases of low blood sugar. Who this helps: This helps patients using GLP-1 RAs and healthcare providers by highlighting the need for better education on their safe use.

Plain English
This study focused on improving cancer treatment using a targeted approach with a radioactive substance called Actinium-225 (Ac). Researchers developed a new tool, the Bio-Sample Alpha Detector (BAD), which can measure how Ac behaves in pancreatic cancer cells, finding that 97% of the radioactivity detected came from the cancer cells after treatment. This method helps scientists better understand how well these treatments work and their potential effects on cells, which is crucial for developing safer and more effective cancer therapies. Who this helps: This helps patients with metastatic cancers and their doctors.

Plain English
This research focused on frailty in people with hemophilia, a condition that has become more prevalent due to longer life expectancies from better treatments. It found that those with severe hemophilia and joint damage are more likely to experience frailty, which can lead to issues like falls and hospitalizations. Addressing frailty early can significantly improve health outcomes through personalized care, indicating a need for better awareness and support for aging individuals with hemophilia. Who this helps: Patients with hemophilia and their healthcare teams.

Plain English
This study looked at patients with chronic diseases who are interested in unproven stem cell treatments. Researchers interviewed 36 patients and caregivers and found that those who are highly interested in these treatments often ignore or downplay the risks, while those who are less interested are more aware of potential dangers. This is important because understanding why some patients are drawn to unproven treatments can help improve how health information is communicated to them. Who this helps: This helps patients by making sure they receive clearer information about the risks and benefits of unproven stem cell interventions.

Plain English
This study looked at how many medical students applied for Pediatrics residency while also applying to other specialties from 2009 to 2023. It found that fewer students are applying to Pediatrics alone (down from 65.9% to 48.4%) and that the average number of different specialties they are applying to has slightly decreased, even though the total number of applications has increased overall. This matters because it indicates that applicants are feeling more pressure and may need better support from medical schools and residency programs. Who this helps: This helps medical students and residency programs.

Plain English
This study looked at how often people experience issues related to hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobility spectrum disorders (HSDs), focusing on their symptoms and the challenges in getting diagnosed. Among almost 4,000 participants with hEDS, they reported an average of 24 other health conditions and waited about 22 years before receiving a diagnosis; common issues included gastrointestinal disorders and chronic pain. The findings show that these conditions are more complex than previously thought, affecting multiple body systems, which highlights the need for better diagnostic tools and understanding of the underlying causes. Who this helps: This helps patients with hEDS and HSDs by identifying their struggles and the need for more comprehensive care.

Plain English
This study looked at how an Augmented Reality (AR) system, called Hoth, can help surgeons remove a specific type of brain tumor called a thoracic meningioma. The AR system allowed the surgeon to see a 3D image of the tumor and surrounding tissue while operating, helping to plan the surgery and locate the tumor more accurately. The system registered the 3D model to the patient in under 30 seconds, improving surgical precision and planning. Who this helps: This benefits surgeons and patients undergoing tumor removal surgeries.

Plain English
This study looked at how two drugs, enmetazobactam and tazobactam, work against a specific type of antibiotic resistance caused by the GES-1 enzyme in bacteria. Researchers found that these drugs affect the enzyme in different ways and discovered that instead of breaking down into a certain expected product, the enzyme can regenerate, which is unusual for this type of resistance. This is important because it helps scientists understand how to create more effective antibiotics in the future. Who this helps: This helps patients with bacterial infections that are resistant to common antibiotics.

Plain English
This study looked at hypermobile Ehlers-Danlos syndrome (hEDS), a condition that causes joint hypermobility, chronic pain, and other health issues. Researchers found changes in a gene called KLK15 in 14 out of 15 related gene families among 200 hEDS patients, which may be involved in how connective tissues work. Specifically, they discovered that a specific change in KLK15 affects connective tissue, suggesting that the condition involves more than just collagen problems and also relates to immune system interactions. Who this helps: This research benefits patients with hypermobile Ehlers-Danlos syndrome and their doctors by providing new insights into the disease.

Plain English
This study looked at Hypermobile Ehlers-Danlos Syndrome (hEDS), a condition that affects connective tissues and is not well understood. Researchers examined blood samples from 29 women with hEDS and compared them to 29 healthy women, identifying 35 proteins that are present in different amounts in hEDS patients. Notably, 43% of these proteins are linked to the immune system, and the study found significant reductions in several specific proteins related to inflammation, indicating that hEDS is not just a connective tissue issue but also involves immune system problems. Who this helps: This helps patients with hEDS by providing insights for better diagnoses and potential treatments.

Plain English
This study looked at how often people were hospitalized for pulmonary embolism (PE) in England from 2008 to 2024, especially during the COVID-19 pandemic. Researchers found that hospital admissions for first-time PE increased from 5.4 cases per 100,000 people in 2008 to 16.8 cases per 100,000 in January 2021 due to COVID-19, but then fell back to around 8.6 per 100,000 by March 2023. Understanding these trends is important for healthcare planning and ensuring that patients get the right care moving forward. Who this helps: This benefits patients at risk for pulmonary embolism and healthcare providers managing their treatment.

Plain English
This study examined whether measuring vancomycin levels at the midpoint of its dosing could accurately predict how the drug behaves in critically ill cancer patients. Researchers found that using the midpoint method provided results that were relatively close to the traditional peak and trough measurements, with an average area under the curve of 426 mg.dl/hr compared to 464 mg.dl/hr from the standard method. This matters because it could offer a simpler and less costly way to monitor vancomycin levels, which is essential for ensuring effective treatment. Who this helps: This helps doctors and healthcare providers manage vancomycin treatment for critically ill cancer patients.

Plain English
This study looked at the use and effects of emicizumab, a treatment for severe hemophilia A without inhibitors, over three years in the UK. They found that patients who switched to emicizumab experienced a significant decrease in bleeding episodes, with the number of individuals having no treated bleeding rising from 35% to 71%. The results are important because they show emicizumab is effective and safe for managing hemophilia, leading to better health outcomes for patients. Who this helps: This research benefits patients with severe hemophilia A and their healthcare providers.

Plain English
This research paper explores the challenges parents face in raising boys today, focusing on the importance of understanding societal pressures and parenting styles. It highlights that authoritative parenting, emotional support, and mindfulness are crucial in helping boys develop emotional intelligence and resilience throughout their lives. The findings emphasize that positive parenting practices can significantly improve boys’ mental health and identity formation in a fast-changing world. Who this helps: This helps parents and clinicians working with boys.

Plain English
This study looked at whether platelet-rich plasma (PRP) injections could improve the appearance of aging skin on women's hands compared to saline injections. Eighteen women received PRP in one hand and saline in the other for 12 weeks, but there were no noticeable improvements in skin quality or patient-reported outcomes between the two treatments. Overall, the research found that PRP did not effectively rejuvenate aging hand skin. Who this helps: This information is useful for patients considering PRP for hand skin rejuvenation.

Plain English
This study focused on using a type of stem cell, called Cardiosphere-derived cells (CDCs), to treat Pulmonary Arterial Hypertension (PAH), a serious and incurable lung condition. In a small group of patients, those who received CDCs showed improvements such as a 6-minute walking distance increase compared to those who received a placebo, along with stable lung function over 12 months. The study found that CDCs were safe with no serious side effects, suggesting they could be a promising treatment for PAH. Who this helps: This helps patients with Pulmonary Arterial Hypertension.

Plain English
This study looked at how well the RTS,S/AS01 malaria vaccine works compared to new vaccine candidates using mice. Researchers found that when mice received two or three doses of RTS,S/AS01, it reduced liver infection from the malaria parasite by 50% at a specific antibody level, while higher antibody levels were necessary for complete protection from mosquito bites. These findings are important because they provide a reliable way to test new malaria vaccines against a known standard, which can help speed up the development of more effective vaccines. Who this helps: This helps researchers developing malaria vaccines.

Plain English
Researchers gathered in August 2023 to discuss ways to improve HIV vaccines by combining two types of immune responses: B-cell and T-cell responses. They reviewed information about the best vaccine candidates and talked about how to enhance overall protection against HIV. The insights from this workshop are important for developing safer and more effective vaccines, which can significantly reduce the spread of HIV. Who this helps: This helps patients at risk for HIV and public health efforts to combat the virus.

Plain English
Researchers studied a new gene therapy called valoctocogene roxaparvovec for treating severe hemophilia A in 134 adult men. Over three years, the therapy significantly reduced bleeding events from an average of 4.8 incidents per year to just 0.97, and patients' need for standard factor VIII treatment dropped by about 97%. This is important because it shows that the gene therapy can greatly improve quality of life for people with this condition while maintaining safety. Who this helps: This helps patients with severe hemophilia A.

Plain English
This study looked at over 2,100 patients with hypermobile Ehlers-Danlos syndrome (hEDS) to better understand their symptoms and related health issues. Researchers found three different groups of patients based on their symptoms and health conditions, which showed that traditional methods of assessing their health may not be accurate. This is important because it can lead to better diagnosis and treatment plans tailored to the specific needs of hEDS patients. Who this helps: This research benefits patients with hEDS and their healthcare providers.

Plain English
This study looked at how a new drug, BA6b9, affects atrial fibrillation (AF) in rats that have heart failure. Researchers found that after giving BA6b9 to the rats for three weeks, it not only made their hearts more stable—reducing the chances and duration of AF—but also prevented structural changes in the heart associated with this condition. Specifically, BA6b9 improved heart function by reversing harmful changes in heart tissue, showing its potential as a better treatment for patients with both AF and heart failure. Who this helps: This helps patients with atrial fibrillation and heart failure.

Plain English
This study focused on the use of platelet-rich plasma (PRP) as a treatment for androgenetic alopecia, a common form of hair loss. The researchers detailed their specific methods for preparing and applying PRP, which helps create a consistent approach to treatment. Standardizing these practices is important because it can lead to better and more reliable results for patients dealing with hair loss. Who this helps: This benefits patients suffering from hair loss due to androgenetic alopecia.

Plain English
Researchers studied the genetic causes of hypermobile Ehlers-Danlos syndrome (hEDS), a condition affecting connective tissue. They found a specific genetic change in the Kallikrein gene (KLK15 p. Gly226Asp) linked to hEDS in two families and discovered a higher frequency of similar genetic changes in 197 hEDS patients. This research is significant because it helps identify genetic markers that can lead to earlier diagnosis and improve treatment for people with this condition. Who this helps: This benefits patients with hypermobile Ehlers-Danlos syndrome and their healthcare providers.

Plain English
This research explored how patients with short bowel syndrome (SBS) can safely use blood-thinning medications called anticoagulants and anti-clotting agents known as antiplatelets. The study found that warfarin was effective even for patients with very short intestines (as short as 12 cm) and that other anticoagulants like rivaroxaban and apixaban can work well too, depending on the intestine length. However, there was very little information on the use of antiplatelet medications, making it hard to offer clear guidance on their use. Who this helps: This information benefits patients with short bowel syndrome and their doctors by providing safer medication options.

Plain English
The study compared how well veterans and nonveterans improved their speech recognition after getting cochlear implants, a device that helps people hear better. Researchers looked at 83 veterans and matched them with 83 nonveterans by age and initial hearing ability. They found that both groups had similar increases in their speech scores after three, six, and twelve months, meaning veterans do as well as nonveterans with this treatment. Who this helps: This benefits veterans needing hearing improvement through cochlear implants.

Plain English
This study looked at the issue of suicidal thoughts and behaviors among people with autism. It found that better understanding of mental health conditions, timing of diagnosis, and emotional challenges helps recognize and reduce suicide risks. However, there's still a need for more focused research on protective factors and personalized care strategies. Who this helps: This benefits autistic individuals and their caregivers by providing better support and intervention options.

Plain English
The study looked at how members of the FDA’s Medical Devices Advisory Committee view the process for approving new medical devices and how it could be improved. Out of 92 panel members, 64 responded, and while most found the FDA's information unbiased, only 45.9% believed that pivotal studies were generally well-designed. Respondents expressed a strong desire for better study designs, more meaningful clinical data (especially from other countries), and an increased role in shaping device labels and trial designs. Who this helps: This benefits patients by potentially leading to safer and more effective medical devices.

Plain English
This study looked at how to better educate patients about unproven stem cell treatments that are often misleadingly marketed. It found that clear and persuasive education can help correct false information and encourage patients to be cautious when considering these experimental therapies. This matters because it aims to protect patients from potential harm caused by false claims and ensures they make informed choices regarding their health. Who this helps: Patients considering stem cell treatments.

Plain English
This study looked at a protein called factor XIII-A (FXIII-A) found in platelets, which are small cells that help our blood clot. Researchers found that FXIII-A makes it easier for platelets to stick together and form strong clots; specifically, without it, platelets struggled to bind to each other and form stable clots, showing a 40% decrease in their ability to spread on surfaces. This matters because understanding how FXIII-A works can help improve treatments for conditions related to blood clotting, like injuries or surgeries. Who this helps: This helps patients who require better blood clotting during surgeries or after injuries.

Plain English
This study looked at how multiple myeloma (MM) and its treatments affect blood platelets, which are important for blood clotting. Researchers found that patients with multiple myeloma, its precursor conditions (smoldering myeloma and monoclonal gammopathy), and those treated with Lenalidomide had significantly more reactive platelets, making them more prone to forming clots. For example, after treatment with Lenalidomide, patients showed increased platelet reactivity, contributing to a higher risk of blood clots during certain blood flow conditions. Who this helps: This research benefits patients with multiple myeloma and their doctors by providing insights into the risks of blood clots associated with treatment.

Plain English
This study examined how diverse the patient populations were in clinical studies that supported the Surviving Sepsis Campaign guidelines for treating sepsis and septic shock. It found that while the number of male patients in these studies ranged from 47% to 62%, most participants were White (68-77%), and 77-99% of studies came from high-income countries, mainly Europe and North America. To improve these guidelines for a wider range of patients, researchers need to work on including more diverse groups in clinical studies. Who this helps: This benefits patients by ensuring that treatment guidelines are applicable to a broader, more diverse population.

Plain English
This study looked at Tyvaso DPI, a new inhaler that delivers a medication called treprostinil to treat pulmonary arterial hypertension and related lung issues. The findings show that Tyvaso DPI is just as effective as the standard nebulizer while being easier to use, with high patient satisfaction and a low rate of side effects. This matters because it offers a convenient treatment option for patients who want a portable and simple way to manage their condition without the hassle of more complex devices. Who this helps: Patients with pulmonary arterial hypertension and related lung diseases.

Plain English
This study looked at an 18-year-old baseball pitcher who had elbow pain for 18 months due to a torn ligament. After receiving an injection of platelet-rich plasma (PRP) and undergoing physical therapy, he experienced significant improvements, feeling less pain and allowing him to return to throwing at full strength after three months. This approach is important because it shows that non-surgical treatments like PRP can effectively help athletes recover from elbow injuries. Who this helps: This helps young athletes with elbow injuries.